iShares U.S. Pharmaceuticals ETF (IHE)
Financial Services · Asset Management
1 member of Congress has disclosed 2 trades in iShares U.S. Pharmaceuticals ETF (IHE) since 2015: 1 buy and 1 sale. The most recent was disclosed on Feb 13, 2018.
- Trades disclosed
- 2
- Members trading
- 1
- Buys / sells
- 1 / 1
- Reported value
- $2K–$30K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at IHE
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded IHE
- Sen. Bill Cassidy (R-LA)1 buy · 1 sale11Feb 13, 2018
All trades
- Feb 13, 2018$1K–$15K
Sen. Bill Cassidy (R-LA)
Sold (full) iShares U.S. Pharmaceuticals ETF IHE
$1K–$15K · Traded Jan 31, 2018 · disclosed Feb 13, 2018 · Spouse
- Aug 28, 2015$1K–$15K
Sen. Bill Cassidy (R-LA)
Bought iShares U.S. Pharmaceuticals ETF IHE
$1K–$15K · Traded Aug 27, 2015 · disclosed Aug 28, 2015 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.